Product Categories
| Country: | China |
|---|---|
| Tel: | 177-54423994 |
| Mobile: | 17754423994 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Ganitumab | 905703-97-1 | Details |
| BAY85-8501 | C22H17F3N4O3S | 1161921-82-9 | Details |
| GV-58 | C18H26N6OS | 1402821-41-3 | Details |
| Cl-Amidine | C14H19ClN4O2 ? CF3CO2H | 1043444-18-3 | Details |
| PRL-3 Inhibitor I | C17H11Br2NO2S2 | 893449-38-2 | Details |
| Sacituzumab | 1796566-95-4 | Details |
| Tuvirumab | 138660-97-6 | Details |
| Elinzanetant | C33H35F7N4O3 | 929046-33-3 | Details |
| Abemaciclib Metabolites M2 | C25H28F2N8 | 1231930-57-6 | Details |
| Vodobatinib | C27H20ClN3O2 | 1388803-90-4 | Details |
| F-901318 | C28H27FN6O2 | 1928707-56-5 | Details |
| Briakinumab | 339308-60-0 | Details |
| Tadocizumab | 339086-80-5 | Details |
| Lumiliximab | 357613-86-6 | Details |
| SU4984 | C20H19N3O2 | 186610-89-9 | Details |
| Bavituximab | 648904-28-3 | Details |
| Basiliximab | 179045-86-4 | Details |
| Clenoliximab | 182912-58-9 | Details |
| Ilginatinib | C21H20FN7 | 1239358-86-1 | Details |
| Galiximab | 357613-77-5 | Details |
| JNJ38877605 | C20H12F2N6 | 943540-74-7 | Details |
| Keliximab | 174722-30-6 | Details |
| Sulesomab | 167747-19-5 | Details |
| BMS 986299 | C18H19N7O | 2242952-69-6 | Details |
| TL895 | C25H26FN5O2 | 1415823-49-2 | Details |
| BAY-1830839 | C22H25F3N4O3 | 1931994-80-7 | Details |
| Vimseltinib | C23H25N7O2 | 1628606-05-2 | Details |
| M-8891 | C20H17F2N3O3 | 1464842-09-8 | Details |
| Tositumomab | 208921-02-2 | Details |
| Zabedosertib | C20H21F3N4O4S | 1931994-81-8 | Details |
| Oregovomab | 213327-37-8 | Details |
| Milatuzumab | 899796-83-9 | Details |
| Mitumomab | 216503-58-1 | Details |
| Biciromab | 138783-13-8 | Details |
| Nofetumomab | 165942-79-0 | Details |
| Afelimomab | 156227-98-4 | Details |
| Inolimomab | 152981-31-2 | Details |
| ABAGOVOMAB | 792921-10-9 | Details |
| Gavilimomab | 244096-20-6 | Details |
| Edobacomab | 141410-98-2 | Details |
| Igovomab | 171656-50-1 | Details |
| Supinoxin | C22H24FN5O4 | 888478-45-3 | Details |
| Otilimab | 1638332-55-4 | Details |
| CX-1632 | C20H17FN4O3 | 1038984-31-4 | Details |
| Imciromab | 126132-83-0 | Details |
| ADH-503 | C22H15NO4S2 | 2055362-72-4 | Details |
| (EZ)-GO289 | C17H15BrN4O2S | 694522-87-7 | Details |
| Dynarrestin | C22H23F2N3O2S | 2222768-84-3 | Details |
| ADH-503 | C27H29N2O5S2+ | 2055362-74-6 | Details |
| Bertilimumab | 375348-49-5 | Details |
| Tralokinumab | 1044515-88-9 | Details |
| Fresolimumab | 948564-73-6 | Details |
| Lerdelimumab | 285985-06-0 | Details |
| OATD01 | C19H27ClN6O | 2088453-21-6 | Details |
| Tafenoquine succinate | C28H34F3N3O7 | 106635-81-8 | Details |
| Lexatumumab | 845816-02-6 | Details |
| Mapatumumab | 658052-09-6 | Details |
| Metelimumab | 272780-74-2 | Details |
| N-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide | C13H14FNO2 | 143655-58-7 | Details |
| MC-Gly-Gly-Phe | C23H28N4O7 | 1599440-15-9 | Details |
| Fmoc-Gly-Gly-Phe-OtBu | C32H35N3O6 | 236426-37-2 | Details |
| Lu-AF27139 | C21H19ClF3N5O2S | 2097117-06-9 | Details |
| Eliapixant | C22H21F3N4O3S | 1948229-21-7 | Details |
| ADX-102 | C12H13ClN2O | 916056-79-6 | Details |
| ITI-214(phosphate） | C29H29FN7O5P | 1642303-38-5 | Details |
| Bunamidine HCl | C25H39ClN2O | 1055-55-6 | Details |
| RIPA-56 | C13H19NO2 | 1956370-21-0 | Details |
| N-(3-Fluoro-4-methyl-5-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide | C13H14FNO2 | 182182-29-2 | Details |
| 4-(2-Acetamido-4-fluoro-5-methylphenyl)butanoic acid | C13H16FNO3 | 182182-28-1 | Details |
| N,N-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydronaphthalene-1,7-diyl)diacetamide | C15H17FN2O3 | 143655-70-3 | Details |
| CFI-401870 | C30H31N5O2 | 1430741-35-7 | Details |
| RAD51-IN-17 | C22H16ClN3O | 2101739-18-6 | Details |
| CNQX | C9H4N4O4 | 115066-14-3 | Details |
| Lefamulin Acetate | C30H49NO7S | 1350636-82-6 | Details |
| RMC-4630 | C20H27ClN6O2S | 2172652-48-9 | Details |
| LGD-6972 | C43H46N2O5S | 1207989-09-0 | Details |
| GSK-1520489A | C21H23N5O3S | 1042433-41-9 | Details |
| 1A-116 | C16H16F3N3 | 1430208-73-3 | Details |
| IM156 | C15H20F3N5O3 | 1422365-94-3 | Details |
| WIN54954 | C18H20Cl2N2O3 | 107355-45-3 | Details |
| Dimethyl carbate | C11H14O4 | 39589-98-5 | Details |
| Teclozan | C20H28Cl4N2O4 | 5560-78-1 | Details |
| ABT-384 | C25H34F3N5O2 | 868623-40-9 | Details |
| MEISi-2 | C18H14N2O3 | 2250156-71-7 | Details |
| 3,5-Dibromo-4-chloro-1H-pyrazole | C3HBr2ClN2 | 27258-21-5 | Details |
| 1H-Imidazo[4,5-c]quinolin-4-amine, 1-(4-aminobutoxy)-2-butyl- | C18H25N5O | 1359993-63-7 | Details |
| 1,2-Bis(2-chloropyridin-3-yl)diselane | C10H6Cl2N2Se2 | 1094062-82-4 | Details |
| Rimcazole dihydrochloride | C21H29Cl2N3 | 75859-03-9 | Details |
| (R)-2-(piperazin-2-yl)acetonitrile | C6H11N3 | 2250242-65-8 | Details |
| MK2-IN-3 hydrate | C21H18N4O2 | 1186648-22-5 | Details |
| PF-06873600 | C20H27F2N5O4S | 2185857-97-8 | Details |
| 1-(sec-butyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | C13H23BN2O2 | 2222997-43-3 | Details |
| PMX205 | C45H62N10O6 | 514814-49-4 | Details |
| 4-Bromo-2-fluoro-3-(trifluoromethyl)aniline | C7H4BrF4N | 159329-03-0 | Details |
| Belzutifan | C17H12F3NO4S | 1672668-24-4 | Details |
| CB-6644 | C29H34ClFN4O5 | 2316817-88-4 | Details |
| 4-amino-3-fluoro-2-methoxybenzonitrile | C8H7FN2O | 1272719-22-8 | Details |
| 6-(3-(Oxazol-2-yl)propyl)pyridin-3-amine | C11H13N3O | 1398048-78-6 | Details |
| S-Amisulpride | C17H27N3O4S | 71675-92-8 | Details |
| Product Total： Product Page： | ||||
| 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 | ||||